Antiproliferative and proapoptotic effect of ascorbyl stearate in human pancreatic cancer cells: association with decreased expression of insulin-like growth factor 1 receptor.

Department of Biochemistry and Nutrition, Central Food Technological Research Institute, Mysore 570013, India.
Digestive Diseases and Sciences (Impact Factor: 2.55). 02/2003; 48(1):230-7. DOI: 10.1023/A:1021779624971
Source: PubMed

ABSTRACT Pancreatic cancer is an aggressive tumor with short median survival and high mortality rate. Alternative therapeutic modalities are currently being evaluated for pancreatic cancer. Here we studied the effects of ascorbyl stearate (Asc-S), a nontoxic, lipophilic derivative of ascorbic acid, on pancreatic cancer. Treatment of human pancreatic carcinoma cells with Asc-S (50-200 microM) resulted in a dose-dependent inhibition of their proliferation. Asc-S slowed down the cell cycle, accumulating, PANC-1 cells in late G2-M phase. Furthermore, Asc-S treatment (150 microM) markedly inhibited growth in soft agar and facilitated apoptosis of PANC-1 cells but not of Capan-2 cells. These effects were accompanied by a significant reduction in insulin-like growth factor 1 receptor (IGF1-R) expression, as compared to untreated controls. Interestingly, Capan-2 cells, the least responsive to Asc-S treatment, did not overexpress the IGF1-R. The results demonstrate the efficacy of Asc-S in inhibing growth of pancreatic cancer cells and warrant additional studies to explore the potential utility of this compound as an alternative and/or adjuvant therapeutic modality for pancreatic cancer.

  • International Journal of Oncology 10/2013; DOI:10.3892/ijo.2013.2159 · 2.77 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Although fully treatable in the early stages, once cervical cancer has metastasized, patient outcome is poor. The main objective of this study was to examine the effect of dietary supplementation with a nutrient mixture (NM) containing lysine, ascorbic acid, proline, green tea extract and other micronutrients on HeLa cell xenografts in nude female mice. Tumor growth was measured and immunohistochemical staining was evaluated for the following cancer markers: Ki67 (proliferation); matrix metalloproteinase (MMP)-2 and -9 (invasion/metastasis); vascular endothelial growth factor (VEGF) (angiogenesis); terminal deoxynucleotidyl transferase dUTP nick end labeling (TUNEL) and B-cell lymphoma 2 (Bcl-2) (apoptosis); cyclooxygenase 2 (COX-2) and inducible nitric oxide synthase (iNOS) (inflammation); and glutathione S-transferase π (GSTπ) (a general cancer marker). Following housing for a week, 5/6-week-old female athymic nude mice (n=12) were inoculated subcutaneously with 3×10(6) HeLa cells in 0.2 ml phosphate-buffered saline and 0.1 ml Matrigel™ and randomly divided into two groups; control group mice were fed regular mouse chow and NM group mice the regular diet supplemented with 0.5% NM (w/w). After four weeks, the mice were sacrificed and their tumors were excised and processed for histology. The NM strongly inhibited the growth of HeLa xenografts in nude mice. The mean tumor weight was reduced to 59% (P=0.001) in the mice fed the NM compared with the tumor weight in the controlled diet mice. Ki67, MMP-2 and -9, VEGF, TUNEL, Bcl-2, COX-2, iNOS and GSTπ all showed a lower intensity and frequency of staining in the NM group compared with that in the control group. In conclusion, NM supplementation strongly inhibited tumor growth and cancer markers in female nude mice injected with HeLa xenografts.
    Experimental and therapeutic medicine 02/2015; 9(2):294-302. DOI:10.3892/etm.2014.2127 · 0.94 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Resumen El empleo de terapias radiantes en tejidos malignos presenta el inconveniente de afectar también a los tejidos sanos, sobre todo cuando éstos presentan una alta tasa de proliferación como en el caso de la mucosa del intestino delgado. El factor de crecimiento de tipo insulínico-1 (IGF-1) ha sido señalado como un posible protector de tejidos normales en condiciones de irradiación. El objetivo de este trabajo fue evaluar el efecto del IGF-1 como radioprotector de la mucosa del intestino delgado en ratones irradiados con 10 Gy a cuerpo entero, determinando las características histológicas del tejido, la presencia de células apoptóticas, la expresión de antígeno de proliferación celular (PCNA) y de enzimas antioxidantes. Se utilizaron cuatro grupos de ratones: control, tratados con IGF-1, irradiados e irradiados y tratados con IGF-1. Los dos grupos tratados fueron inyectados subcutáneamente con dos dosis por día de 2.5 µg de IGF-I /0.1ml durante cuatro días (días 1 a 4). Los dos grupos irradiados recibieron 10 Gy a cuerpo entero el día 2. El día 5 todos los animales fueron sacrificados y se obtuvieron cortes de la mucosa del intestino delgado. Los cortes histológicos se evaluaron por tinción con hematoxilina-eosina; la presencia de células apoptóticas se determinó por el método Tunel (Apoptag kit); la expresión de PCNA, superóxido dismutasa dependiente de cobre y zinc (CuZnSOD), superóxido dismutasa dependiente de manganeso (MnSOD), catalasa (CAT) y glutatión peroxidasa (GPX), por inmunohistoquímica. Los resultados demostraron que el tratamiento con IGF-1 preservó parcialmente la histología de la mucosa del intestino, la expresión de PCNA y la presencia de células apoptóticas en las criptas frente a la irradiación. La CuZnSOD se expresó sobre todo en las vellosidades y, en menor medida, en las criptas aumentó en el grupo IR+IGF-1. El IGF-1 produjo la expresión de MnSOD en las criptas y en las vellosidades intestinales. La expresión de CAT en las vellosidades aumentó significativamente en el grupo tratado con IGF-1 e irradiado, con respecto a los demás grupos. Concluimos que el tratamiento con IGF-1 induce la reparación y/o proliferación en la mucosa intestinal irradiada, previene la muerte celular apoptótica y modula positivamente la expresión de enzimas antioxidantes, actuando de este modo como radioprotector de la misma.


Available from
Jan 6, 2015